Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil

Abstract Background Inconsistent monitoring of prostate-specific antigen in patients receiving 5-alpha reductase inhibitors for lower urinary tract symptoms/benign prostate enlargement may affect prostate cancer outcomes. This study evaluated real-world practice among urologists treating patients re...

Повний опис

Бібліографічні деталі

Автори:	Juan Manuel Palacios, Pratiksha Kapse, Vanessa Cortes, Marcio Augusto Averbeck, Alberto Budia Alba, Suryakant Somvanshi, Danilo Souza Lima da Costa Cruz, Fiona Pereira
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2025-01-01
Серія:	BMC Urology
Предмети:	5-alpha reductase inhibitors Benign prostatic hyperplasia Benign prostate enlargement Prostate-specific antigen Real-world data
Онлайн доступ:	https://doi.org/10.1186/s12894-025-01701-1
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!